AstraZeneca’s COVID-19 vaccines made by Siam Bioscience pass quality testing in Europe and U.S.
AstraZeneca announced today that the samples from test batches of the COVID-19 vaccine made by Siam Bioscience had passed quality testing at AstraZeneca’s designated laboratories in Europe and in the U.S.
Mr. James Teague, Country President, AstraZeneca (Thailand) Ltd., said: “We have seen significant and promising progress in AstraZeneca’s COVID-19 vaccine development in Thailand during past weeks. First, the Thai Food and Drug Administration approved Siam Bioscience as a manufacturing facility for the COVID-19 Vaccine AstraZeneca.
NNT Reporter
